Breast Cancer Clinical Trial
— PSSOfficial title:
Assessment Of Patient Satisfaction Of Outpatient Care In The Multi-Disciplinary Breast Clinic- Linguistic Validation Study
| NCT number | NCT03962595 |
| Other study ID # | 1835 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | March 23, 2017 |
| Est. completion date | December 31, 2019 |
Patient satisfaction is the primary means of assessing the effectiveness of primary health
care delivery. It helps in improving the quality of care by identifying and help resolving
the potential problem areas. It assesses the effectiveness of the care provided and document
the quality to accrediting organisations.In our institute, we have developed a patient
satisfaction survey (PSS) questionnaire and have conducted a pilot study (Institutional
review board approved) with fifty English speaking breast cancer patients receiving active
cancer directed treatment in outpatient clinic, to evaluate the level of patient satisfaction
in them. Therefore, we are now conducting a linguistic validation study using Hindi and
Marathi PSS questionnaire to assess the overall level of patient satisfaction in a larger
cohort of patients with diverse linguistic and economic background attending both general and
private Outpatient Clinic.
The aim of the study is to evaluate the overall level of patient satisfaction and their
satisfaction at various encounters in the multi-disciplinary Breast Clinic which can be
helpful to improve various aspects of patient care delivery.
Methods:
All patients who have already sort primary consultation in surgical, medical and radiation
oncology outpatient clinics for their treatment plan and have had their last consultation
within the last one month will be screened for the study. The Patient Satisfaction Survey
(PSS) questionnaire (in preferred language) will be administered independently by a clinical
research student who is not directly involved in patient care. The PSS will be anonymous. It
will be administered to patients in the out-patient clinics waiting area. Patients will be
asked to complete 3 surveys: one each for surgical, medical and radiation oncology
professionals. It will take approximately 12 months to enroll the required number of
patients.
Sample size: Previous studies conducted in India and the pilot study conducted at Tata
Memorial Hospital (TMH) with the PSS questionnaire have shown that approximately 70% of the
patients are satisfied with the health care services. Assuming that the proportion of
patients satisfied with the health services, when assessed by Hindi and Marathi PSS
questionnaire will be ± 5% of 70%, i.e. between 65% to 75%, a sample size of 340 will be
needed to produces a two-sided 95% confidence interval, which is determined by using
Confidence Intervals Formula- Clopper-Pearson method.
Potential Impact of the Study
1. Knowledge of patient satisfaction in breast cancer patients belonging to diverse
linguistic and socio-economic background will help in improving the quality of life of
patients using appropriate resources and measures relevant to Indian context.
2. Awareness of patient dissatisfaction will help improve doctor patient relationship.
3. Awareness of patient dissatisfaction will help to identify problem areas and improve the
care delivery.
| Status | Recruiting |
| Enrollment | 340 |
| Est. completion date | December 31, 2019 |
| Est. primary completion date | December 31, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: 1. Women with histological confirmation of breast cancer. 2. Planned to receive multi-disciplinary curative active cancer directed treatment. 3. Aware of their diagnosis and treatment plan. 4. Willingness to participate in study. 5. Patient able to read and comprehend Hindi and Marathi. - Exclusion Criteria: 1. Eastern Cooperative Oncology Group 4 2. Unable to read and fill the questionnaire - |
| Country | Name | City | State |
|---|---|---|---|
| India | Tata Memorial Centre | Mumbai | Maharashtra |
| Lead Sponsor | Collaborator |
|---|---|
| Tata Memorial Centre |
India,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Linguistic validation of patient satisfaction survey (PSS) questionnaires in Hindi and Marathi. | Scoring: For each of the rated 25 items, a score of 1-5 will be assigned. This gives a maximum score of 125 and a minimum score of 25. A score of 75 or above indicates that patient is satisfied with the care provided. Construct validity for the instrument will be assessed using Pearson's correlation between the items and scales (It-Sc i.e. convergent validity) and between scales (Sc-Sc i.e. discriminant validity). The correlation coefficient should be >0.4 and <0.7 for these respectively. Internal consistency (scale reliability) of the multi item questionnaires will be tested by Cronbach alpha coefficient. The internal consistency should be 0.70 or higher when scales are used for group comparisons. |
1 Year | |
| Secondary | Proportion of patients having mean overall satisfaction score <70 | The distribution of patients having low satisfaction score < 70 across surgical, medical and radiation oncology will be studied and the comments provided by patients will help understand the reasons related to low satisfaction. | 1 Year | |
| Secondary | To compare the level of overall patient satisfaction between paid and service patients: percentage of patients having overall score below 75 of the maximum 125 | The comments provided by patients will help understand the reasons related to low satisfaction and the difference between the two classes of patients will be known from the percentage of patients having overall score below 70 of the maximum 125 | 1Year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |